Results 61 to 70 of about 101,493,672 (203)

Quality of life after transcatheter edge-to-edge mitral valve repair: A prospective observational cohort study

Annales Academiae Medicae Silesiensis
Introduction: In patients with heart failure (HF), left ventricular remodelling can lead to secondary mitral regurgitation (SMR), which exacerbates HF symptoms and reduces quality of life (QoL). Transcatheter edge-to-edge repair (TEER), an interventional
Tomasz Gallina, Marta Marks, Marek Jędrzejek, Wojciech Wojakowski, Grzegorz Smolka, Ewa Peszek-Przybyła   +5 more
doaj   +1 more source

The durability of different anchoring points and anchoring types in the left ventricle in an ex vivo porcine model

Clinical Physiology and Functional Imaging, Volume 46, Issue 6, November 2026.
Abstract Objective Surgical mitral valve repair, including anchoring in different parts of the mitral apparatus, is the standard of care for severe mitral regurgitation. Various percutaneous approaches have been developed and are currently under development, but are struggling with durable results.
Henrik Bjursten, Per Wierup, Sasha Koul, Matthias Götberg, Magnus Dencker   +4 more
wiley   +1 more source

Evaluation of Changes in the Cardiac Function before and after Transcatheter Edge-to-Edge Mitral Valve Repair in Healthy Dogs: Conventional and Novel Echocardiography

Animals, 2021
Mitral valve regurgitation is a common canine heart disease. Transcatheter Edge-to-Edge Repair (TEER) is a transcatheter, edge-to-edge mitral repair device that uses a hybrid approach.
Kenta Sasaki, Danfu Ma, Ahmed S. Mandour, Yusuke Ozai, Tomohiko Yoshida, Katsuhiro Matsuura, Aki Takeuchi, Chieh-Jen Cheng, Hussein M. El-Husseiny, Hanan Hendawy, Kazumi Shimada, Lina Hamabe, Akiko Uemura, Ryou Tanaka   +13 more
doaj   +1 more source

Transcatheter Edge-to-edge Repair of Severe Tricuspid Regurgitation [PDF]

, 2019
Despite the increasing knowledge of the long-term adverse consequence of severe tricuspid regurgitation (TR), most patients with moderate- to-severe TR are still treated conservatively because of the high risk of surgery.
Edwin C Ho, Michel Zuber, Mizuki Miura, Mara Gavazzoni, Francesco Maisano, Shu-I Lin, Maurizio Taramasso, Alberto Pozzoli, Maisano, Francesco, Pozzoli, Alberto, Zuber, Michel, Ho, Edwin C, Lin, Shu-I, Gavazzoni, Mara, Miura, Mizuki, Taramasso, Maurizio   +15 more
core   +1 more source

Impact of mitral valve interventions on left ventricular hemodynamics: Insights into energy loss and flow dynamicsCentral MessagePerspective

JTCVS Open
Objectives: Left ventricular vortex dynamics play a crucial role in cardiac function but are significantly altered by mitral valve diseases or surgical interventions.
Shuyi Feng, MD, Hongping Wang, PhD, Xinyi He, PhD, Pengxu Kong, MD, Fan Wu, PhD, Shizhao Wang, PhD, Xiangbin Pan, MD, Guowei He, PhD   +7 more
doaj   +1 more source

Aortic valve disease: Novel animal models for advancing our understanding of the underlying mechanisms

Animal Models and Experimental Medicine, Volume 9, Issue 10, Page 1964-1981, October 2026.
Due to the complex pathophysiology of aortic valve disease (AVD) and the resulting lack of effective pharmacotherapy, existing animal models are valuable research tools, but each has its own strengths and limitations. This review systematically surveys the major AVD models, compares their induction methods, pathological features, advantages and ...
Liya Hou, Xue Liu, Wangxing Hu, Xianbao Liu, Wei Zhu   +4 more
wiley   +1 more source

MitraClip for Secondary Mitral Regurgitation

JACC: Case Reports, 2021
We describe the case of an 83-year-old man with a history of ischemic cardiomyopathy and severe secondary mitral regurgitation. This case highlights the role of transcatheter edge-to-edge repair with the MitraClip in the management of symptomatic ...
Brian D. McCauley, MD, MPH, Howard C. Herrmann, MD, Tiffany Chen, MD, Saif Anwaruddin, MD   +3 more
doaj   +1 more source

Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age

Catheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1548-1557, October 1, 2026.
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens, Florian Schindhelm, Mohammed Abusharekh, Jürgen Kampf, Matthias Totzeck, Fadi Al‐Rashid, Peter Lüdike, Tienush Rassaf, Amir A. Mahabadi   +8 more
wiley   +1 more source

Percutaneous Mitral Edge-to-Edge Repair: State of the Art and a Glimpse to the Future. [PDF]

, 2019
Patients with severe symptomatic mitral regurgitation have a poor prognosis if left untreated. In those patients who are not eligible for mitral valve surgery, percutaneous edge-to-edge repair may improve clinical outcomes.
Brugger, Nicolas, Windecker, Stephan, Winkel, Mirjam, Praz, Fabien, Khan, Faisal, Pilgrim, Thomas, Ong, Geraldine, Fam, Neil, Brugger N, Ong G, Windecker S, Fam N, Pilgrim T, Khan F, Praz F, Winkel M   +15 more
core   +2 more sources

Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures

Life
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos, Odysseas Katsaros, Anastasios Apostolos, Maria Drakopoulou, Grigorios Tsigkas, Constantinos Tsioufis, Periklis Davlouros, Konstantinos Toutouzas, Antonios Karanasos   +8 more
doaj   +1 more source